Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine

Journal of Chemotherapy

Volumn 24, Issue 1, 2012, Pages 12-17

  Setchanova, L P ^a   Alexandrova, A ^a   Mitov, I ^a   Nashev, D ^b   Kantardjiev, T ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

Antibiotic resistance; Pneumococcal conjugate vaccine; S. pneumoniae; Serotypes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MEROPENEM; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BULGARIA; CONTROLLED STUDY; ERM(B) GENE; GENOTYPE; MEDICAL DEVICE; MEF(E) GENE; MENINGITIS; NONHUMAN; PNEUMOCOCCAL INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84866259565     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1120009X12Z.0000000004     Document Type: Article

References (25)

1. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec. 2007;82:93-104.
2. Clarke SC. Control of pneumococcal disease in the United Kingdom-the start of a new era. J Med Microbil. 2006;55:975-80.
3. Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2008. MMWR Morb Mortal Wkly Rep. 2008;57(6):144-8.
4. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine. 2003;21(17-18):1815-25.
5. European Medicines Agency (EMEA). Summary of positive opinion for Prevenar 13 [Internet]. London: EMEA; 24 Sep 2009. Available from: http//www.emea.europa.eu/ (Accessed 24 September 2009).
6. World Health Organization. Streptococcus pneumonia (Pneumococcus) [Internet]. [cited 2010 Apr] Available from: http://www.who.int/immunization_delivery/new_vaccines/pneumo.
7. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14(3):e197-209.
8. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8:785-95.
9. Imohl M, Reinert RR, Mutscher C, van der Linden M. Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008. BMC Microbiol. 2010;10:299
10. Sorensen UBS. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol. 1993;31:2097-100.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2010. M100-S20.
12. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detectionof erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother. 1996;40:2562-66.
13. Montanari MP, Mingoia M, Giovanetti E, Varaldo PE. Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy. J Clin Microbiol. 2003;41:428-31.
14. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-46.
15. Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, Ozkan S, et al. Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol. 2011;18(6);1028-30.
16. Zissis NP, Syriopoulou V, Kafetzis D, Daikos GL, Tsilimingaki A, Galanakis E, et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Pediatr. 2004;163(7):364-8.
17. Dobay O, Ungvari A, Kardos S, Kristof K, Hajdu E, Szabo J, et al. Genotypic and phenotypic characterisation of invasive Streptococcus pneumoniae isolates from Hungary, and coverage of the conjugate vaccines. J Clin Pathol. 2010;63(12):1116-20.
18. koczynska A, Sadowy E, Bojarska K, Strzelecki J, Kuch A, Golebiewska A, et al. The current status of invasive pneumococcal disease in Poland. Vaccine. 2011;29(11):2199-205.
19. Setchanova L, Tomasz A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria. J Clin Microbiol. 1999;37:638-48.
20. Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47(4):1012-20.
21. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease du to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196(9):1346-54.
22. Prymula R, Hanovcova I, Splino M, Kriz P, Motlova J, Lebedova V, et al. Impact of the 10-valent pneumococcal non-typable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine. 2011;29(10):1959-67.
23. Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis. 2002;34:1613-20.
24. Setchanova L, Ouzounova-Raykova V, Zhelezova G, Mitov I. Prevalence and macrolide resistance phenotypes and genotypes among clinical isolates of Streptococcus pneumoniae collected in Sofia, Bulgaria from 2001 to 2005. J Chemother. 2007;19:256-62.
25. Setchanova L. Clinical isolates and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in hospital for infectious diseases, Sofia, Bulgaria, 1991-1993. Microbial Drug Resist. 1995;1:79-84.